The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 16, 2012
Filed:
May. 09, 2008
Young Lag Cho, Daejeon, KR;
Ho Young Song, Daejeon, KR;
Dae Yon Lee, Daejeon, KR;
Sung Yoon Baek, Daejeon, KR;
Sang Eun Chae, Daejeon, KR;
Sang Hui JO, Daejeon, KR;
Yeon OK Kim, Daejeon, KR;
Hyang Sook Lee, Daejeon, KR;
Ju Hyun Park, Daejeon, KR;
Tae Kyo Park, Daejeon, KR;
Sung Ho Woo, Daejeon, KR;
Yong Zu Kim, Daejeon, KR;
Young Lag Cho, Daejeon, KR;
Ho Young Song, Daejeon, KR;
Dae Yon Lee, Daejeon, KR;
Sung Yoon Baek, Daejeon, KR;
Sang Eun Chae, Daejeon, KR;
Sang Hui Jo, Daejeon, KR;
Yeon Ok Kim, Daejeon, KR;
Hyang Sook Lee, Daejeon, KR;
Ju Hyun Park, Daejeon, KR;
Tae Kyo Park, Daejeon, KR;
Sung Ho Woo, Daejeon, KR;
Yong Zu Kim, Daejeon, KR;
Legochem Bioscience Ltd., Daejeon, KR;
Abstract
The present invention relates to novel oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof, and processes for preparing the same, and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof can be usefully employed as an anticoagulant for treating thromboembolism and tumors via inhibition of coagulation factor Xa.